Exane Derivatives’s Acadia Healthcare ACHC Stock Holding History

Exane Derivatives’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$135	Sell	2 -15	-88%	-$1.05K	﹤0.01%	704
2022 Q1	$1.11K	Hold	17	–	–	﹤0.01%	798
2021 Q4	$1.03K	Hold	17	–	–	﹤0.01%	708
2021 Q3	$1.08K	Hold	17	–	–	﹤0.01%	854
2021 Q2	$1.04K	Sell	17 -2,627	-99%	-$165K	﹤0.01%	873
2021 Q1	$151K	Buy	2,644 +2,640	+66,000%	+$143K	0.04%	335
2020 Q4	$201	Buy	+4	New	+$159	﹤0.01%	795
2020 Q2	–	Sell	-3,268	Closed	-$60K	–	688
2020 Q1	$60K	Buy	+3,268	New	+$93.6K	0.02%	343

Other funds holding ACHC

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Exane Derivatives's ACHC Position: Q2 2022 in Review

Exane Derivatives reduced its Acadia Healthcare (ACHC) stake by 88% in Q2 2022, selling an estimated $1.05K and leaving 2 shares worth $135. The position accounts for ﹤0.01% of the portfolio, ranked #704.

Exane Derivatives first reported a position in ACHC in Q1 2020 and has held it in 8 quarters since. The position peaked at $151K in Q1 2021. 284 funds tracked by Wall St. Rank hold ACHC as of Q2 2022.

Exane Derivatives held 2 shares of Acadia Healthcare worth $135 as of Q2 2022.
Exane Derivatives sold 15 Acadia Healthcare shares in Q2 2022, an estimated $1.05K.
Acadia Healthcare made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #704 holding.
Exane Derivatives first reported a position in Acadia Healthcare in Q1 2020 and has held it in 8 quarters since.
Exane Derivatives's Acadia Healthcare position peaked at $151K in Q1 2021.
284 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.